L3VLUP
ProSign in

NVS in the 13F filings

Novartis AG · CUSIP 66987V109

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2023
the date the book describes
Filed
14 Nov 2023
latest of these filings; the earliest 13 Nov 2023
Managers listing it
10
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q2 2023 and Q3 2023; 9 listed it in both
Shares listed
28,746,680
combined, among listed positions
Reported value
$2.9bn
combined, at the quarter end

Managers listing NVS in Q3 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

10 of 10 holders

ActionFiling
Dodge & Cox16,264,221$1.7bn1.12%Trimmed-142,89214 Nov 2023 (the filing on sec.gov)
Wellington Management Group LLP4,691,916$478m0.10%Trimmed-60,03614 Nov 2023 (the filing on sec.gov)
Renaissance Technologies LLC2,636,845$269m0.46%Added+282,00014 Nov 2023 (the filing on sec.gov)
Janus Henderson Group Ltd2,532,937$258m0.17%Trimmed-68,32914 Nov 2023 (the filing on sec.gov)
Marshall Wace LLP1,057,042$108m0.22%Added+14,73014 Nov 2023 (the filing on sec.gov)
Capital Research Global Investors903,617$92munder 0.1%Added+37413 Nov 2023 (the filing on sec.gov)
Holocene Advisors LP243,609$25m0.11%Newnew14 Nov 2023 (the filing on sec.gov)
Voloridge Investment Management LLC204,305$21m0.10%Trimmed-307,21914 Nov 2023 (the filing on sec.gov)
Point72 Asset Management LP181,247$18m0.05%Trimmed-725,03914 Nov 2023 (the filing on sec.gov)
Capital World Investors30,941$3.2munder 0.1%Added+90913 Nov 2023 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2023 to Q3 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
7 in Q3 2024 to 9 in Q2 2026

Tracked managers listing it, at least.

051015202014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
NVS by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201310$4.4bnn.a.n.a.
Q3 20138$4.7bnn.a.n.a.
Q4 20139$4.7bnn.a.n.a.
Q1 201410$4.9bnn.a.n.a.
Q2 20149$5.5bnn.a.n.a.
Q3 201414$5.8bnn.a.n.a.
Q4 201414$5.7bnn.a.n.a.
Q1 201513$6.2bnn.a.n.a.
Q2 201514$6.1bnn.a.n.a.
Q3 201515$5.0bnn.a.n.a.
Q4 201515$4.8bnn.a.n.a.
Q1 201615$4.1bnn.a.n.a.
Q2 201610$4.5bnn.a.n.a.
Q3 201612$4.3bnn.a.n.a.
Q4 20168$3.9bnn.a.n.a.
Q1 201712$4.5bnn.a.n.a.
Q2 201714$4.9bnn.a.n.a.
Q3 201714$4.6bnn.a.n.a.
Q4 201711$4.5bnn.a.n.a.
Q1 201817$4.5bnn.a.n.a.
Q2 201817$4.5bnn.a.n.a.
Q3 201811$5.2bnn.a.n.a.
Q4 201817$5.6bnn.a.n.a.
Q1 201914$6.4bnn.a.n.a.
Q2 201913$5.2bnn.a.n.a.
Q3 201915$4.9bnn.a.n.a.
Q4 201913$5.3bnn.a.n.a.
Q1 202015$4.2bnn.a.n.a.
Q2 202010$4.1bnn.a.n.a.
Q3 202010$3.8bnn.a.n.a.
Q4 202010$3.7bnn.a.n.a.
Q1 20219$3.1bnn.a.n.a.
Q2 202113$3.8bnn.a.n.a.
Q3 202110$3.9bnn.a.n.a.
Q4 202114$4.4bnn.a.n.a.
Q1 202214$4.4bnn.a.n.a.
Q2 202213$3.8bnn.a.n.a.
Q3 202213$3.2bnn.a.n.a.
Q4 202211$3.9bnn.a.n.a.
Q1 202315$3.5bnn.a.n.a.
Q2 202311$3.0bnn.a.n.a.
Q3 202310$2.9bnn.a.n.a.
Q4 202310$2.5bn73
Q1 20249$2.3bn72
Q2 20249$2.5bn36
Q3 20247$2.7bn35
Q4 20248$2.2bn53
Q1 20259$2.6bn55
Q2 20259$2.6bn46
Q3 20257$2.3bn16
Q4 20257$2.0bn1216
Q1 20266$1.7bn1414
Q2 20269$999m1713

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

NVS and LLY →NVS and JNJ →NVS and VRTX →Choose a stock to compare with NVS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own NVS, latest filings →Back to the 13F Explorer →